429 related articles for article (PubMed ID: 32150549)
1. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial.
Yu EW; Gao L; Stastka P; Cheney MC; Mahabamunuge J; Torres Soto M; Ford CB; Bryant JA; Henn MR; Hohmann EL
PLoS Med; 2020 Mar; 17(3):e1003051. PubMed ID: 32150549
[TBL] [Abstract][Full Text] [Related]
2. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.
Allegretti JR; Kassam Z; Mullish BH; Chiang A; Carrellas M; Hurtado J; Marchesi JR; McDonald JAK; Pechlivanis A; Barker GF; Miguéns Blanco J; Garcia-Perez I; Wong WF; Gerardin Y; Silverstein M; Kennedy K; Thompson C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):855-863.e2. PubMed ID: 31301451
[TBL] [Abstract][Full Text] [Related]
3. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
[TBL] [Abstract][Full Text] [Related]
4. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial.
Leong KSW; Jayasinghe TN; Wilson BC; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
JAMA Netw Open; 2020 Dec; 3(12):e2030415. PubMed ID: 33346848
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.
Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH
Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.
Mocanu V; Zhang Z; Deehan EC; Kao DH; Hotte N; Karmali S; Birch DW; Samarasinghe KK; Walter J; Madsen KL
Nat Med; 2021 Jul; 27(7):1272-1279. PubMed ID: 34226737
[TBL] [Abstract][Full Text] [Related]
7. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
[TBL] [Abstract][Full Text] [Related]
8. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial.
Ng SC; Xu Z; Mak JWY; Yang K; Liu Q; Zuo T; Tang W; Lau L; Lui RN; Wong SH; Tse YK; Li AYL; Cheung K; Ching JYL; Wong VWS; Kong APS; Ma RCW; Chow EYK; Wong SKH; Ho ICH; Chan PKS; Chan FKL
Gut; 2022 Apr; 71(4):716-723. PubMed ID: 33785557
[TBL] [Abstract][Full Text] [Related]
9. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
[TBL] [Abstract][Full Text] [Related]
10. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
[TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study.
de Clercq NC; van den Ende T; Prodan A; Hemke R; Davids M; Pedersen HK; Nielsen HB; Groen AK; de Vos WM; van Laarhoven HWM; Nieuwdorp M
Clin Cancer Res; 2021 Jul; 27(13):3784-3792. PubMed ID: 33883174
[TBL] [Abstract][Full Text] [Related]
12. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial.
Fretheim H; Chung BK; Didriksen H; Bækkevold ES; Midtvedt Ø; Brunborg C; Holm K; Valeur J; Tennøe AH; Garen T; Midtvedt T; Trøseid M; Zarè H; Lund MB; Hov JR; Lundin KEA; Molberg Ø; Hoffmann-Vold AM
PLoS One; 2020; 15(5):e0232739. PubMed ID: 32437393
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.
Allegretti JR; Kassam Z; Carrellas M; Mullish BH; Marchesi JR; Pechlivanis A; Smith M; Gerardin Y; Timberlake S; Pratt DS; Korzenik JR
Am J Gastroenterol; 2019 Jul; 114(7):1071-1079. PubMed ID: 30730351
[TBL] [Abstract][Full Text] [Related]
15. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.
Nicolucci AC; Hume MP; Martínez I; Mayengbam S; Walter J; Reimer RA
Gastroenterology; 2017 Sep; 153(3):711-722. PubMed ID: 28596023
[TBL] [Abstract][Full Text] [Related]
16. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
[TBL] [Abstract][Full Text] [Related]
17. Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity.
Allegretti JR; Kassam Z; Hurtado J; Marchesi JR; Mullish BH; Chiang A; Thompson CC; Cummings BP
Hormones (Athens); 2021 Mar; 20(1):209-211. PubMed ID: 33420959
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
20. Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain.
Rinott E; Youngster I; Yaskolka Meir A; Tsaban G; Zelicha H; Kaplan A; Knights D; Tuohy K; Fava F; Scholz MU; Ziv O; Rubin E; Tirosh A; Rudich A; Blüher M; Stumvoll M; Ceglarek U; Clement K; Koren O; Wang DD; Hu FB; Stampfer MJ; Shai I
Gastroenterology; 2021 Jan; 160(1):158-173.e10. PubMed ID: 32860791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
